Flagship Harbor Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Flagship Harbor Advisors’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-885	Closed	-$286K	–	682
2023 Q4	$286K	Buy	885 +196	+28%	+$61.4K	0.02%	505
2023 Q3	$247K	Hold	689	–	–	0.02%	525
2023 Q2	$261K	Buy	689 +225	+48%	+$91.6K	0.02%	512
2023 Q1	$222K	Buy	+464	New	+$217K	0.02%	564
2020 Q4	–	Sell	-144	Closed	-$74K	–	666
2020 Q3	$74K	Sell	144 -45	-24%	-$22.8K	0.01%	741
2020 Q2	$85K	Buy	189 +151	+397%	+$66.6K	0.01%	694
2020 Q1	$13K	Buy	38 +37	+3,700%	+$13.6K	﹤0.01%	1148
2019 Q4	$0	Buy	+1	New	+$353	﹤0.01%	1877
2018 Q4	–	Sell	-68	Closed	-$21K	–	1851
2018 Q3	$21K	Sell	68 -3	-4%	-$931	﹤0.01%	1096
2018 Q2	$20K	Buy	+71	New	+$19.6K	﹤0.01%	1092

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Flagship Harbor Advisors's BIO Position: Q1 2024 in Review

Flagship Harbor Advisors sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2024, closing a stake of 885 shares — an estimated $286K sold.

Flagship Harbor Advisors first reported a position in BIO in Q2 2018 and held it in 10 quarters. The position peaked at $286K in Q4 2023. 467 funds tracked by Wall St. Rank hold BIO as of Q1 2024.

Flagship Harbor Advisors reported no remaining Bio-Rad Laboratories Class A position as of Q1 2024 after selling out during the quarter.
Flagship Harbor Advisors sold 885 Bio-Rad Laboratories Class A shares in Q1 2024, an estimated $286K.
Flagship Harbor Advisors first reported a position in Bio-Rad Laboratories Class A in Q2 2018 and held it in 10 quarters.
Flagship Harbor Advisors's Bio-Rad Laboratories Class A position peaked at $286K in Q4 2023.
467 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2024.

Based on Flagship Harbor Advisors's 13F filing for Q1 2024, filed 16 Apr 2024.